Portal Hypertension Therapeutics - Pipeline Assessment and Market Forecasts to 2019

Feb. 9, 2012 - PRLog -- GlobalData estimated the global portal hypertension therapeutics market to be valued at $1.7 billion in
2011. It is expected to grow to $1.9 billion at a Compound Annual Growth Rate (CAGR) of 2.0% by 2019.
This slow growth is due to the slow increase in the prevalent population, the domination of the market by generics and low likelihood of new product launches during the forecast period.

GlobalData’s analysis found that the unmet need in the portal hypertension market is significant, which implies that the market is not well served by the current treatment options. There are no drugs approved for the treatment of portal hypertension. The market is dominated by off-label generic drugs. Betablockers are the drugs mainly used for treatment of portal hypertension. However, due to contraindications and side effects beta-blocker therapy is discontinued in many patients. Therefore there is a need for novel drugs with better safety and efficacy profiles to capture the untapped market.

GlobalData’s analysis showed that the portal hypertension therapeutics pipeline is weak with only three molecules in clinical development. There are no molecules in Phase III. There is one molecule in Phase II/III, but it is sponsored by an academic institution. The company sponsored molecules are in Phase II and are unlikely to have an impact on the market during the forecast period. Thus the portal hypertension market provides scope for new entrants with novel mechanisms of action aimed at the cause of the disease with better safety and efficacy profiles.

For Sample Pages, please click or add the below link to your browser:
http://www.globaldata.com/reportstore/RequestSamplePages....


GlobalData, the industry analysis specialist, has released its new report, “Portal Hypertension Therapeutics - Pipeline Assessment and Market Forecasts to 2019”. The report is an essential source of information and analysis on the global Portal Hypertension Therapeutics market. The report identifies the key trends shaping and driving the global Portal Hypertension Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Portal Hypertension Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

For further details, please click or add the below link to your browser:
http://www.globaldata.com/reportstore/Report.aspx?ID=Port...


Visit our report store: http://www.globaldata.com/reportstore

For more details contact:
pressreleases@globaldata.com        
North America:    +1 646 395 5477
Europe:        +44 207 753 4299
           +44 1204 543 533
Asia Pacific:       +91 40 6616 6782

# # #

GlobalData is a global market intelligence services company providing information research and analysis products and services.